Clinical trial
RATe Control in Atrial Fibrillation
NCT00313157 · Asker & Baerum Hospital, Other · Completed
Key facts
| NCT number | NCT00313157 |
|---|---|
| Title | RATe Control in Atrial Fibrillation |
| Official title | Rate Control in Atrial Fibrillation |
| Acronym | RATAF |
| Lead sponsor | Asker & Baerum Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Metoprolol, Diltiazem, Verapamil, Carvedilol |
| Enrollment | 80 |
| Start date | Apr 1, 2006 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Apr 12, 2006 |
| Last update posted | May 13, 2014 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: